Predicting long-term progression of Alzheimer's disease using a multimodal deep learning model incorporating interaction effects

Yifan Wang,Ruitian Gao,Ting Wei,Luke Johnston,Xin Yuan,Yue Zhang,Zhangsheng Yu,,Yue Zhang and Zhangsheng Yu
DOI: https://doi.org/10.1186/s12967-024-05025-w
IF: 8.44
2024-03-12
Journal of Translational Medicine
Abstract:Identifying individuals with mild cognitive impairment (MCI) at risk of progressing to Alzheimer's disease (AD) provides a unique opportunity for early interventions. Therefore, accurate and long-term prediction of the conversion from MCI to AD is desired but, to date, remains challenging. Here, we developed an interpretable deep learning model featuring a novel design that incorporates interaction effects and multimodality to improve the prediction accuracy and horizon for MCI-to-AD progression.
medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to accurately predict the long - term risk of mild cognitive impairment (MCI) patients progressing to Alzheimer's disease (AD). Specifically, the goal of the paper is to improve the prediction accuracy and time range of MCI - to - AD conversion by developing a deep - learning model that combines multi - modal data (structural magnetic resonance imaging, clinical assessment, and genetic polymorphism data) and interaction effects. This not only helps with early intervention but also improves the care of pre - dementia patients. The main contributions of the paper are as follows: 1. **Model Design**: Proposed a deep - learning model (DISFC) with a dual - interaction module, which can effectively handle the complex interaction relationships within and between modalities. 2. **Performance Improvement**: Significantly improved the prediction accuracy by integrating multi - modal data and interaction effects. 3. **Robustness**: The model performs consistently on different clinical centers and scanners, showing good generalization ability. 4. **Interpretability**: Utilized the Shapley Additive Explanation (SHAP) method to reveal the contribution of multi - modal biomarkers to the model's prediction ability, enhancing the model's interpretability. These improvements make the DISFC model superior to existing methods in predicting the long - term progression from MCI to AD, providing a powerful tool for clinical decision - support.